Table 1.
Characteristics of study population by HAART status at Burayu Health center, Addis Ababa, Ethiopia, 2012
| Variable |
HAART initiated (n=126) |
Non-HAART (n=126) |
|
|---|---|---|---|
| N (%) | N (%) | ||
| Gender |
Female |
86(68.3) |
96(76.2) |
| Male |
40(31.7) |
30(23.8) |
|
| Age group (years) |
Mean ± SD |
37.1(9.8) |
33.4(10.2) |
| 18-29 |
25(19.8) |
51(40.5)** |
|
| 30-39 |
61(48.4) |
49(38.9) |
|
| 40-49 |
25(19.8) |
16(12.7) |
|
| ≥50 |
15(11.9) |
10(7.9) |
|
| BMI |
Mean ± SD |
21.9(3.2) |
20.8(2.8) |
| <18.5 |
9(7.1) |
24(19)* |
|
| 18.5-24.9 |
97(77) |
91(72.2) |
|
| 25-29.9 |
17(13.5) |
10(7.9) |
|
| ≥30 |
3(2.4) |
1(0.8) |
|
| CD4+ cells (cells/mm3) |
Mean ± SD |
314.5 ± 152.5 |
413.6 ± 246.2 |
| <200 |
34(27) |
25(19.8)** |
|
| 200-400 |
58(46) |
42(33.3) |
|
| >400 |
34(27) |
59(46.8) |
|
| Duration of HIV infection (month) |
Mean ± SD |
29.5(17) |
11.8(12.3) |
| <6 |
0(0) |
57(45.2)*** |
|
| 6-12 |
22(17.5) |
21(16.7) |
|
| 13-24 |
22(17.5) |
27(21.4) |
|
| 25-41 |
59(46.8) |
19(15.1) |
|
| ≥42 |
23(18.3) |
2(1.6) |
|
| TB Co-infection | Present |
21(16.7) |
18(14.3) |
| Not present | 105(83.3) | 108(85.7) | |
N, number; BMI, body mass index; HAART, highly active antiretroviral therapy; TB, tuberculosis; SD, standard deviation; *p-value =0.02; **p-value =0.004; ***p-value <0.0001.